4.7 Article

Lamin A/C-mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy

Journal

JOURNAL OF CELL BIOLOGY
Volume 184, Issue 1, Pages 31-44

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1083/jcb.200811035

Keywords

-

Categories

Funding

  1. National Institutes of Health (NIH)
  2. NCI
  3. Center for Cancer Research
  4. Institut National de la Santet de la Recherche Medicale (INSERM)
  5. Assistance Publique-Hopitaux de Paris
  6. Association Francaise contreles Myopathies (AFM)
  7. European Union Fifth Framework [018690]
  8. Association Francaise contre les Myopathies (AFM) [10722]

Ask authors/readers for more resources

he LMNA gene encodes lamins A and C, two intermediate filament-type proteins that are important determinants of interphase nuclear architecture. Mutations in LMNA lead to a wide spectrum of human diseases including autosomal dominant Emery-Dreifuss muscular dystrophy (AD-EDMD), which affects skeletal and cardiac muscle. The cellular mechanisms by which mutations in LMNA cause disease have been elusive. Here, we demonstrate that defects in neuromuscular junctions (NMJs) are part of the disease mechanism in AD-EDMD. Two AD-EDMD mouse models show innervation defects including misexpression of electrical activity dependent genes and altered epigenetic chromatin modi. cations. Synaptic nuclei are not properly recruited to the NMJ because of mislocalization of nuclear envelope components. AD-EDMD patients with LMNA mutations show the same cellular defects as the AD-EDMD mouse models. These results suggest that lamin A/C mediated NMJ defects contribute to the AD-EDMD disease phenotype and provide insights into the cellular and molecular mechanisms for the muscle-specific phenotype of AD-EDMD.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available